Target intelligence / Profile preview

LysM, putative peptidoglycan-binding, domain containing 4 pseudogene

Molecular classification
Pseudogene, Other
01

Overview

This gene entry, "LysM, putative peptidoglycan-binding, domain containing 4 pseudogene" (ENSG00000251300/LOC100287014), is classified as a human pseudogene and does not encode a functional protein. The LysM domain is a widely conserved carbohydrate-binding module present in thousands of proteins across prokaryotes and eukaryotes, primarily associated with binding to peptidoglycan and chitin and involved in functions like cell wall recognition, symbiosis, and innate immunity in other species[2][4]. In bacteria and some eukaryotes, LysM domains can mediate binding to polysaccharides or function as part of enzymes involved in cell wall metabolism[1][2][4]. However, in this pseudogene, there is no evidence of expression, function, or therapeutic relevance in humans. Therefore, it does not meet criteria for consideration as a molecular target, therapeutic receptor, or biomarker[5].

Other names
ENSG00000251300LOC100287014

Beyond the preview

Go deeper on LysM, putative peptidoglycan-binding, domain containing 4 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LysM, putative peptidoglycan-binding, domain containing 4 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call